These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 191213

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Renal sensitivity to angiotensin II in the conscious dog.
    Siragy HM, Lamb NE, Woodson JF, Ragsdale NV, Rose CE, Peach MJ, Carey RM.
    Endocrinology; 1987 Apr; 120(4):1272-8. PubMed ID: 3549257
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Intrarenal Mas and AT1 receptors play a role in mediating the excretory actions of renal interstitial angiotensin-(1-7) infusion in anaesthetized rats.
    O'Neill J, Healy V, Johns EJ.
    Exp Physiol; 2017 Dec 01; 102(12):1700-1715. PubMed ID: 28940861
    [Abstract] [Full Text] [Related]

  • 26. Angiotensin II in the renal excretory response to behavioral stress in conscious dogs.
    Koepke JP, Obrist PA.
    Am J Physiol; 1983 Aug 01; 245(2):R259-64. PubMed ID: 6349389
    [Abstract] [Full Text] [Related]

  • 27. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS, Gavras H, Hood WB.
    J Clin Invest; 1978 Apr 01; 61(4):874-83. PubMed ID: 659580
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB, Laragh JH.
    Ann Intern Med; 1979 Aug 01; 91(2):153-60. PubMed ID: 464461
    [Abstract] [Full Text] [Related]

  • 30. Renal blockade to angiotensin II in acute and chronic sodium-retaining states.
    Slick GL, DiBona GF, Kaloyanides GJ.
    J Pharmacol Exp Ther; 1975 Nov 01; 195(2):185-93. PubMed ID: 1185590
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ, Casals-Stenzel J, Lever AF, Millar JA, Riegger AJ, Tree M.
    Br J Clin Pharmacol; 1979 Nov 01; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [Abstract] [Full Text] [Related]

  • 34. Intrarenal role of angiotensin II and [des-Asp1]angiotensin II.
    Hall JE, Coleman TG, Guyton AC, Balfe JW, Salgado HC.
    Am J Physiol; 1979 Mar 01; 236(3):F252-9. PubMed ID: 426067
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Control of glomerular filtration rate by circulating angiotensin II.
    Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP.
    Am J Physiol; 1981 Sep 01; 241(3):R190-7. PubMed ID: 7025662
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intrarenal effects of the renin-angiotensin system.
    Ploth DW, Navar LG.
    Fed Proc; 1979 Aug 01; 38(9):2280-5. PubMed ID: 456614
    [No Abstract] [Full Text] [Related]

  • 40. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC, Ploth DW, Navar LG.
    Clin Sci (Lond); 1982 Jun 01; 62(6):573-9. PubMed ID: 7083749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.